Public Reporting of Outcomes (Standard 1.12)

In 2018 we conducted the following quality and improvement studies:


Standard 4.6: Utility of Left Ventricular Ejection Fraction Measurements Before the Administration of Doxorubicin-Based Chemotherapy in Patients With Diffuse Large B-Cell Lymphoma Study

To determine the utility of routine measurements of left ventricular ejection fraction (LVEF) before the administration of doxorubicin-based chemotherapy (DOX) in patients with diffuse large B-cell lymphoma (DLBCL).

Conclusion

The decision to administer DOX was influenced by LVEF status only when previous CD was factored out. Furthermore, CHF incidence posttreatment did not differ between patients who did and did not receive DOX. These preliminary findings challenge the practice of performing cardiac screening before DOX for patients with DLBCL.

Additional details about the studies can be found here:


Improvement in Palliative Care Referrals in Oncology Clinic Study

Assess quality of current palliative care referral process in the oncology clinic. Hold two day Kaizen event with goal of of operationalizing automatic referrals for patients with stage 4 or non resectable cancers, and optimize clinic workflows through the creation of a Palliative Care Needs Assessment, sorting mechanism to determine which discipline(s) should be involved depending on the patient’s unique situation, and standard work for referrals to Palliative Care. The goal was also to assess staff’s baseline knowledge and comfort with palliative care and increase education.

Additional details about the studies can be found here: